HL Bonkowsky, JR Bloomer, PS Ebert, MJ Mahoney. Heme synthetase deficiency in human protoporphyria. Demonstration of the defect in liver and cultured skin fibroblasts. „J Clin Invest”. 56 (5), s. 1139-48, Nov 1975. DOI: 10.1172/JCI108189. PMID: 1184741.
JR Bloomer. Characterization of deficient heme synthase activity in protoporphyria with cultured skin fibroblasts. „J Clin Invest”. 65 (2), s. 321-8, Feb 1980. DOI: 10.1172/JCI109675. PMID: 7356682.
SA Holme, AV Anstey, AY Finlay, GH Elder i inni. Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life. „Br J Dermatol”. 155 (3), s. 574-81, Sep 2006. DOI: 10.1111/j.1365-2133.2006.07472.x. PMID: 16911284.
SA Holme, M Worwood, AV Anstey, GH Elder i inni. Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria. „Blood”. 110 (12), s. 4108-10, Dec 2007. DOI: 10.1182/blood-2007-04-088120. PMID: 17804693.
J Harms, S Lautenschlager, CE Minder, EI Minder. An alpha-melanocyte-stimulating hormone analogue in erythropoietic protoporphyria. „N Engl J Med”. 360 (3), s. 306-7, Jan 2009. DOI: 10.1056/NEJMc0805682. PMID: 19144952.
JH Harms, S Lautenschlager, CE Minder, EI Minder. Mitigating Photosensitivity of Erythropoietic Protoporphyria Patients by an Agonistic Analog of alpha-Melanocyte Stimulating Hormone. „Photochem Photobiol”, Jul 2009. DOI: 10.1111/j.1751-1097.2009.00595.x. PMID: 19656325.
dx.doi.org
LaurentL.GouyaLaurentL. i inni, Contribution of a common single-nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria, „American Journal of Human Genetics”, 78 (1), 2006, s. 2-14, DOI: 10.1086/498620, PMID: 16385445.
S. AlexanderS.A.HolmeS. AlexanderS.A. i inni, Seasonal palmar keratoderma in erythropoietic protoporphyria indicates autosomal recessive inheritance, „The Journal of investigative dermatology”, 129 (3), 2009, s. 599-605, DOI: 10.1038/jid.2008.272, ISSN1523-1747, PMID: 18787536.
Sharon D.S.D.WhatleySharon D.S.D. i inni, C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload, „American Journal of Human Genetics”, 83 (3), 2008, s. 408-14, DOI: 10.1016/j.ajhg.2008.08.003, PMID: 18760763.
SS.ThunellSS., PP.HarperPP., AA.BrunAA., Porphyrins, porphyrin metabolism and porphyrias. IV. Pathophysiology of erythyropoietic protoporphyria--diagnosis, care and monitoring of the patient, „Scand J Clin Lab Invest”, 60 (7), 2000, s. 581-604, DOI: 10.1080/003655100448347, PMID: 11202051. Cytat za: Lecha, 2009
Brendan M.B.M.McGuireBrendan M.B.M. i inni, Liver transplantation for erythropoietic protoporphyria liver disease, „Liver Transpl”, 11 (12), 2005, s. 1590-6, DOI: 10.1002/lt.20620, PMID: 16315313.
Elizabeth B.E.B.RandElizabeth B.E.B. i inni, Sequential liver and bone marrow transplantation for treatment of erythropoietic protoporphyria, „Pediatrics”, 118 (6), 2006, e1896-9, DOI: 10.1542/peds.2006-0833, PMID: 17074841.
IngridI.WinshipIngridI. i inni, Antioxidant effect of warfarin therapy: a possible symptomatic treatment for erythropoietic protoporphyria, „Archives of Dermatology”, 145 (8), 2009, s. 960-1, DOI: 10.1001/archdermatol.2009.165, PMID: 19687444.
nih.gov
ncbi.nlm.nih.gov
IA Magnus, A Jarrett, TA Prankerd, C Rimington. Erythropoietic protoporphyria. A new porphyria syndrome with solar urticaria due to protoporphyrinaemia. „Lancet”. 2 (7200), s. 448-51, Aug 1961. PMID: 13765301.
HL Bonkowsky, JR Bloomer, PS Ebert, MJ Mahoney. Heme synthetase deficiency in human protoporphyria. Demonstration of the defect in liver and cultured skin fibroblasts. „J Clin Invest”. 56 (5), s. 1139-48, Nov 1975. DOI: 10.1172/JCI108189. PMID: 1184741.
JR Bloomer. Characterization of deficient heme synthase activity in protoporphyria with cultured skin fibroblasts. „J Clin Invest”. 65 (2), s. 321-8, Feb 1980. DOI: 10.1172/JCI109675. PMID: 7356682.
LN Went, EC Klasen. Genetic aspects of erythropoietic protoporphyria. „Ann Hum Genet”. 48 (Pt 2), s. 105-17, May 1984. PMID: 6742776.
LaurentL.GouyaLaurentL. i inni, Contribution of a common single-nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria, „American Journal of Human Genetics”, 78 (1), 2006, s. 2-14, DOI: 10.1086/498620, PMID: 16385445.
S. AlexanderS.A.HolmeS. AlexanderS.A. i inni, Seasonal palmar keratoderma in erythropoietic protoporphyria indicates autosomal recessive inheritance, „The Journal of investigative dermatology”, 129 (3), 2009, s. 599-605, DOI: 10.1038/jid.2008.272, ISSN1523-1747, PMID: 18787536.
Sharon D.S.D.WhatleySharon D.S.D. i inni, C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload, „American Journal of Human Genetics”, 83 (3), 2008, s. 408-14, DOI: 10.1016/j.ajhg.2008.08.003, PMID: 18760763.
HW Lim. Pathophysiology of cutaneous lesions in porphyrias. „Semin Hematol”. 26 (2), s. 114-9, Apr 1989. PMID: 2658087. Cytat za: Lecha, 2009
SS.ThunellSS., PP.HarperPP., AA.BrunAA., Porphyrins, porphyrin metabolism and porphyrias. IV. Pathophysiology of erythyropoietic protoporphyria--diagnosis, care and monitoring of the patient, „Scand J Clin Lab Invest”, 60 (7), 2000, s. 581-604, DOI: 10.1080/003655100448347, PMID: 11202051. Cytat za: Lecha, 2009
GH Elder, SG Smith, SJ Smyth. Laboratory investigation of the porphyrias.. „Ann Clin Biochem”. 27 ( Pt 5), s. 395-412, Sep 1990. PMID: 2281921. Cytat za: Lacha, 2009
SA Holme, AV Anstey, AY Finlay, GH Elder i inni. Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life. „Br J Dermatol”. 155 (3), s. 574-81, Sep 2006. DOI: 10.1111/j.1365-2133.2006.07472.x. PMID: 16911284.
CA Henderson, S Jones, G Elder, A Ilchyshyn. Erythropoietic protoporphyria presenting in an adult. „J R Soc Med”. 88 (8), s. 476P-477P, Aug 1995. PMID: 7562835.
JD Fallon, JC Kvedar, RJ Margolis, MA Pathak. Erythropoietic protoporphyria presenting in adulthood. „Arch Dermatol”. 125 (9), s. 1286-7, Sep 1989. PMID: 2774610.
GM Murphy, JL Hawk, IA Magnus. Late-onset erythropoietic protoporphyria with unusual cutaneous features. „Arch Dermatol”. 121 (10), s. 1309-12, Oct 1985. PMID: 4037826.
RA Marsden, RP Dawber. Erythropoietic protoporphyria with onycholysis. „Proc R Soc Med”. 70 (8), s. 572-4, Aug 1977. PMID: 918073.
R Baran, L Juhlin. Photoonycholysis. „Photodermatol Photoimmunol Photomed”. 18 (4), s. 202-7, Aug 2002. PMID: 12390677.
SA Muley, HA Midani, JM Rank, R Carithers i inni. Neuropathy in erythropoietic protoporphyrias. „Neurology”. 51 (1), s. 262-5, Jul 1998. PMID: 9674816.
SA Holme, M Worwood, AV Anstey, GH Elder i inni. Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria. „Blood”. 110 (12), s. 4108-10, Dec 2007. DOI: 10.1182/blood-2007-04-088120. PMID: 17804693.
EI Minder, L Gouya, X Schneider-Yin, JC Deybach. A genotype-phenotype correlation between null-allele mutations in the ferrochelatase gene and liver complication in patients with erythropoietic protoporphyria. „Cell Mol Biol (Noisy-le-grand)”. 48 (1), s. 91-6, Feb 2002. PMID: 11929053.
Brendan M.B.M.McGuireBrendan M.B.M. i inni, Liver transplantation for erythropoietic protoporphyria liver disease, „Liver Transpl”, 11 (12), 2005, s. 1590-6, DOI: 10.1002/lt.20620, PMID: 16315313.
Elizabeth B.E.B.RandElizabeth B.E.B. i inni, Sequential liver and bone marrow transplantation for treatment of erythropoietic protoporphyria, „Pediatrics”, 118 (6), 2006, e1896-9, DOI: 10.1542/peds.2006-0833, PMID: 17074841.
EI Minder, X Schneider-Yin, J Steurer, LM Bachmann. A systematic review of treatment options for dermal photosensitivity in erythropoietic protoporphyria. „Cell Mol Biol”. 55 (1), s. 84-97, 2009. PMID: 19268006.
J Harms, S Lautenschlager, CE Minder, EI Minder. An alpha-melanocyte-stimulating hormone analogue in erythropoietic protoporphyria. „N Engl J Med”. 360 (3), s. 306-7, Jan 2009. DOI: 10.1056/NEJMc0805682. PMID: 19144952.
JH Harms, S Lautenschlager, CE Minder, EI Minder. Mitigating Photosensitivity of Erythropoietic Protoporphyria Patients by an Agonistic Analog of alpha-Melanocyte Stimulating Hormone. „Photochem Photobiol”, Jul 2009. DOI: 10.1111/j.1751-1097.2009.00595.x. PMID: 19656325.
IngridI.WinshipIngridI. i inni, Antioxidant effect of warfarin therapy: a possible symptomatic treatment for erythropoietic protoporphyria, „Archives of Dermatology”, 145 (8), 2009, s. 960-1, DOI: 10.1001/archdermatol.2009.165, PMID: 19687444.
DJ Todd. Erythropoietic protoporphyria. „Br J Dermatol”. 131 (6), s. 751-66, Dec 1994. PMID: 7857832.
MB Poh-Fitzpatrick. Human protoporphyria: reduced cutaneous photosensitivity and lower erythrocyte porphyrin levels during pregnancy. „J Am Acad Dermatol”. 36 (1), s. 40-3, Jan 1997. PMID: 8996259.
epitan. [dostęp 2009-09-28]. [zarchiwizowane z tego adresu (2008-12-05)].
worldcat.org
S. AlexanderS.A.HolmeS. AlexanderS.A. i inni, Seasonal palmar keratoderma in erythropoietic protoporphyria indicates autosomal recessive inheritance, „The Journal of investigative dermatology”, 129 (3), 2009, s. 599-605, DOI: 10.1038/jid.2008.272, ISSN1523-1747, PMID: 18787536.